NPR logo

Glaxo To Stop Paying Doctors To Promote Drugs

  • Download
  • <iframe src="https://www.npr.org/player/embed/251833628/251833642" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
Glaxo To Stop Paying Doctors To Promote Drugs

Business

Glaxo To Stop Paying Doctors To Promote Drugs

Glaxo To Stop Paying Doctors To Promote Drugs

  • Download
  • <iframe src="https://www.npr.org/player/embed/251833628/251833642" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

The head of British drug maker GlaxoSmithKline told The New York Times on Monday that the company will stop paying doctors to promote its drugs. Pharmaceutical firms commonly pay physicians to speak at medical conferences — a practice criticized as a conflict of interest.

LINDA WERTHEIMER, HOST:

NPR's business news starts with new rules for Glaxo.

(SOUNDBITE OF MUSIC)

WERTHEIMER: The head of British - the British drug maker GlaxoSmithKline, told The New York Times yesterday that the company will stop paying doctors to promote its drugs. Pharmaceutical firms commonly pay physicians to speak at medical conferences - a practice criticized as a conflict of interest.

Glaxo's CEO told the company - told the paper - the company would also stop paying all its sales reps based on how many prescriptions doctors write.

Copyright © 2013 NPR. All rights reserved. Visit our website terms of use and permissions pages at www.npr.org for further information.

NPR transcripts are created on a rush deadline by Verb8tm, Inc., an NPR contractor, and produced using a proprietary transcription process developed with NPR. This text may not be in its final form and may be updated or revised in the future. Accuracy and availability may vary. The authoritative record of NPR’s programming is the audio record.